VAERS reports by lot

GSK Varicella/Shingles lot NB9D3: VAERS reports

25 VAERS reports list lot NB9D3 as a GSK Varicella/Shingles vaccine, received between 2020-03-25 and 2021-11-07. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
0%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2227%
General / Systemic (non-local)1822%
Neurological1215%
Dermatological (non-injection-site)1114%
Gastrointestinal67%
Musculoskeletal45%
Cardiac / Cardiovascular34%
Allergic / Anaphylactic34%
Respiratory22%

Where reports came from

U.S. state of the reporter, where given (top 12).

California6
Pennsylvania5
Kansas1
New York1
Virginia1
Nevada1
Wisconsin1
Ohio1
Hawaii1
Texas1
Washington1
New Jersey1

Reports by month received

2020-031
2020-041
2020-052
2020-062
2020-072
2020-082
2020-095
2020-103
2020-113
2021-021
2021-071
2021-112

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.